Homoeopathy in diseases of the jaw bone
- Conditions
- Health Condition 1: M266- Temporomandibular joint disorders
- Registration Number
- CTRI/2023/05/052919
- Lead Sponsor
- Central Council for Research in Homoeopathy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
1. Patients with the complaint of pain at the Temporo Mandibular joint (M26.6)
2. Age: 18 year(s) to 75 year(s)
3. Both sexes
4. Not undertaking regular medicines for any other clinical conditions other than controlled diabetes mellitus, hypertension, hypothyroidism, hypertriglyceridemia and hypercholesteremia
5. Patients suffering from additional acute diseases like acute upper respiratory tract infection, acute gastro-enteritis, acute toothache, and acute sinusitis may be enrolled after a washout period of 1 week following recovery
6. Voluntary written informed consent
1. Patients with self-reported serious co-morbidities like Tuberculosis, Cardiac disorders, HIV AIDS, severe immune-compromised state, Faciomaxillary cancer, and other malignancies
2. Patients with uncontrolled diabetes mellitus, hypertension, hypothyroidism, and dyslipidemia
3. Patient self-reporting of taking chemotherapeutic agents, immunosuppressive medicines, teratogenic drugs, and anti-coagulant medications
3. Suffering from known severe psychiatric disorders like bipolar disorders, schizophrenia, and severe insanity.
4. Undergone surgery related to TMJ dysfunction
5. Pregnant and lactating mothers
6. Not willing to give voluntary informed consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Graded Chronic Pain ScaleTimepoint: Baseline and every month for 3 months
- Secondary Outcome Measures
Name Time Method Jaw Functional Limitation Scale (JFLS) – Long formTimepoint: Baseline and every month for 3 months;Patient Health Questionnaire – 4 (PHQ4)Timepoint: Baseline and at the end of 3rd month;Proportion of adverse events occurring during the study periodTimepoint: From recruitment till end of study;Proportion of cases requiring conventional medicines/surgery and mean medicine dosageTimepoint: Every month follow-up for 3 months